Your browser doesn't support javascript.
loading
Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis: Case Report and Review of Literature.
Galiatsatos, Panagis; Melia, Michael T; Silhan, Leann L.
Afiliación
  • Galiatsatos P; Critical Care Medicine , National Institutes of Health , Bethesda.
  • Melia MT; Divisions of Infectious Diseases.
  • Silhan LL; Pulmonary and Critical Care Medicine , Johns Hopkins Medicine , Baltimore, Maryland.
Open Forum Infect Dis ; 3(2): ofw116, 2016 Apr.
Article en En | MEDLINE | ID: mdl-27419184
ABSTRACT
Allergic bronchopulmonary aspergillosis (ABPA) results from a hypersensitivity response to airways colonization with Aspergillus fumigatus, and it occurs most often in individuals with asthma or cystic fibrosis. Allergic bronchopulmonary aspergillosis is an indolent, but potentially progressive, disease in patients. In patients infected with human immunodeficiency virus (HIV), ABPA is rare, and its description in the literature is limited to case reports. We describe the occurrence of ABPA in a 37-year-old woman with well controlled HIV infection. This represents the first documented case of ABPA in an HIV-infected patient whose only pulmonary comorbidity included the ramifications of prior acute respiratory distress syndrome due to Pneumocystis jirovecii pneumonia. We also review prior case reports of ABPA in HIV-infected patients and consider risk factors for its development.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2016 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2016 Tipo del documento: Article